chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I have degenerative back disease and my doctor had given me a prednisone dose pack for me to have on hand if the pain got out of hand.  When I started having numbness on the right side of my head (especially my eye lid, upper teeth on the right side, right cheek, ear and behind the ear), I first just used prednisone cream, and found it to help, but not fully.   After reading that others had bells palsy after having the shot, and my symptoms seemed similar to bells palsy, I looked up the treatment for bells palsy to be prednisone dose pack.  Since I had one on hand, and online stated it would be best to start immediately to avoid any long term effects, I took the first dose on Friday, March 26th.  Within 20 minutes my tingling started to subside.  I still am experiencing numbness on the right side of my face, but it is significantly reduced, I would say approximately 90% better.
Per Immunization Registry Information System (IRIS), pt received first dose of Moderna COVID-19 vaccine on 1/13/21 at a Medical Center. No second dose was ever reported to IRIS.  Pt came to our pharmacy and received a dose of Janssen COVID-19 vaccine on 9/8/21. On his consent form questionnaire,  pt reported that he had not received a previous dose of COVID-19 vaccine.
Lab values came back out of normal ranges. GFR normally around 58 came back 39 on 5.28.21 and 45 on 5.29.21 and 35 on 6.10.21. Also showing elavated creatine labs. Concerned this may be vaccine related.
pt recv vax 4APR98 & 8APR98 pt devel a fever & sore neck;13APR exp joint pain;14APR broke out in a red itchy, confluent rash described as hive/urticaria on chin, neck, stomach, area, inner elbow, upper thighs  & wrist;
Had been going through menopause for a minimum of one year prior to the shot.  Now, the menstrual cycle occurs about every 10-12 days and lasts 8-10 days with heavy flow compounded by cramps.  I have never had cramps prior to the shots.
No adverse event; Third dose administered  0.3ml; This spontaneous case was reported by an other health care professional and describes the occurrence of INCORRECT DOSE ADMINISTERED (Third dose administered  0.3ml) and NO ADVERSE EVENT (No adverse event) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. FF8839) for COVID-19 prophylaxis.     No Medical History information was reported.   On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .3 milliliter. On 30-Sep-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INCORRECT DOSE ADMINISTERED (Third dose administered  0.3ml). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INCORRECT DOSE ADMINISTERED (Third dose administered  0.3ml) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for INCORRECT DOSE ADMINISTERED (Third dose administered  0.3ml).    No concomitant medication was reported. No treatment medication was reported.   This case was linked to MOD-2022-620415, MOD-2022-608992 (Patient Link).
Outcome: Fever of Unknown Origin, Elevated WBC and Elevated Liver Enzymes ( Transaminases)  Days Sick:  Twice in March, 3/31, 4/20, 4/27, 4/29, 5/8, 5/20, 5/24. On 5/8 fever 103 other days over 102.  F/U with Doctors,
covid-19; covid-19; This is a spontaneous report received from a contactable reporter (Other HCP). The reporter is the patient.  A 56-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 17Mar2021 as dose 1, single (Lot number: FN6207), in left arm, on 04Apr2021 as dose 2, single (Lot number: EW0151), in right arm and on 14Oct2021 as dose 3 (booster), single (Lot number: FF2587) at the age of 55 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing); "multiple sclerosis" (unspecified if ongoing); "GERD" (unspecified if ongoing); "RAD" (unspecified if ongoing); "Osteoarthritis" (unspecified if ongoing); "Diabetes" (unspecified if ongoing). Concomitant medication(s)/Other medication in 2 weeks included: GILENYA; HYDROCHLOROTHIAZIDE; ANASTRAZOLE DENK; MONTELUKAST; ASPIRINE; LOSARTAN; AMLODIPINE; CALCIUM. Past drug history included: Marcaine, reaction(s): "Allergy"; Cipro, reaction(s): "Allergy".  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 17Jun2022, outcome "unknown" and all described as "covid-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Tested positive for covid again six days after finishing paxlovid and continuing to isolate; Negative, notes: Tested negative. 2days after finishing paxlovid; Positive, notes: Tested negative. 2days after finishing paxlovid only to have symptoms return on day six after completion and tested positive for Covid again. Tested positive for covid again six days after finishing paxlovid and continuing to isolate. Tested negative 2days after finishing paxlovid only to have symptoms return on day six after completion and tested positive for Covid again. It was unknown if therapeutic measures were taken as a result of drug ineffective. Therapeutic measures were taken as a result of covid-19.; Sender's Comments: Based on the available reported information, the causal association between the events and the suspect drug BNT162B2 cannot be excluded.
It started as random wrist pain when I would bend it and put it in extreme positions. Then as it got worse I started noticing it during work such as while typing and using a mouse. I was later told it was because it was inflamed, I started taking ibuprofen and CBD to try and help with it. Dr. gave me steroid injections in both wrists and it helped what she believed was carpal tunnel. Then it turned into inflammation of the synovial fluid. The I had blood work that indicated I had markers for the synovial fluid inflammation. I have an appt for another steroid shot in a few days. I also developed a ganglion cyst in my right ankle which gets inflamed sometimes as well.
interstitial keratitis; Shingles; visual disturbance in left eye due to shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient (pt) of unknown age. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On an unknown date, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose# and route not specified) for routine health maintenance and the prevention of shingles (herpes zoster).  On an unknown date, reported as after injection, the patient suffered a painful blistering rash on the left side of his face, forhead and scalps. As a result of his symptoms, the pt presented to a medical provideder and was diagnosed with shingles, as well as, visual disturbance in left eye due to shingles and interstital keratitis. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient's symptoms have resulted in physical limitations not present prior to using the product. The patient also experiences mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of zoster vaccine live (ZOSTAVAX), the patient sustained severe and permanent personal injuries. Further, as a tragic consequence of the Company's wrongful conduct, the pt suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of the Company's conduct, the patient has suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcomes of the events were considered not recovered/not resolved. The events were considered related to zoster vaccine live (ZOSTAVAX).  The events were considered to be disabling. Upon internal review, the events of keratitis interstitial and visual disturbance in left eye due to shingles were determined to be medically significant.
Given Hep A and meningococcal vaccine at 1:45 PM 08/11/03. At 2PM same day, arrived at her home with severe headache, fast heartbeat, slight dizziness, slight nausea, very tired. At 4:40 PM returned to our office with these symptoms, plus hands feel tingly.
Injection given in bursa sac.  Patient started experiencing sever shoulder pain 3 days after vaccine administration.  She was examined by an orthopod and he stated that the vaccine was injected into her bursa.  She is still experiencing pain and loss of use as of present.
Although I did experience extreme headaches and a sore arm within days of getting the vaccine in addition to continuing & excessive fatigue, a little over a week later I had an extreme, painful skin outbreak all over my body. I'm assuming my eczema flared up in reaction to the vaccine, but up until that day my eczema had been dormant and restricted to a mild dry patch on my arm and leg joints. Within an hour, I had red spots and red patches appear all over body, including my stomach and back, where I hadn't had an eczema outbreak in years. My neck was swollen and became extremely wrinkly in appearance, as did my elbows and anywhere else I itched. Although that night was the most abrupt and extreme part of the reaction period, it took 3 days for the flare-up to calm down, the duration of which I was incredibly itchy and experiencing some pain. I took several Benadryl tablets the next day to help calm the itchiness before bedtime.
have not been have 2nd shot (second shot not administered within 35days); surgery after the 1st shot; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (have not been have 2nd shot (second shot not administered within 35days)) and SURGERY (surgery after the 1st shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (have not been have 2nd shot (second shot not administered within 35days)) and SURGERY (surgery after the 1st shot). At the time of the report, PRODUCT DOSE OMISSION ISSUE (have not been have 2nd shot (second shot not administered within 35days)) and SURGERY (surgery after the 1st shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
Both of my upper arms feel like it's hot on the inside; Yeast infection under my breasts; My face & neck red turned red; Rash at the injection site; My arm was sore; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FUNGAL INFECTION (Yeast infection under my breasts), FEELING HOT (Both of my upper arms feel like it's hot on the inside), ERYTHEMA (My face & neck red turned red), INJECTION SITE RASH (Rash at the injection site) and INJECTION SITE PAIN (My arm was sore) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Rosacea and Psoriasis.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced INJECTION SITE PAIN (My arm was sore). On 26-Mar-2021, the patient experienced INJECTION SITE RASH (Rash at the injection site). On 30-Mar-2021, the patient experienced ERYTHEMA (My face & neck red turned red). On 02-Apr-2021, the patient experienced FUNGAL INFECTION (Yeast infection under my breasts). On 08-Apr-2021, the patient experienced FEELING HOT (Both of my upper arms feel like it's hot on the inside). At the time of the report, FUNGAL INFECTION (Yeast infection under my breasts), FEELING HOT (Both of my upper arms feel like it's hot on the inside), ERYTHEMA (My face & neck red turned red), INJECTION SITE RASH (Rash at the injection site) and INJECTION SITE PAIN (My arm was sore) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant medications were not reported.  No treatment details were provided
This spontaneous report as received from a licensed practical nurse refers to 2 unspecified patients of unknown age and gender. There was no information about patients' concomitant medications and pertinent medical history reported. On an unknown date, unspecified 2 patients were vaccinated with doses of improperly stored ROTATEQ (lot # L008577, expiry date 02-DEC-2016 (routes and sites of administration, doses were not reported). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Pt was given Pediarix #3, Prevnar #3 and Rotavirus #3 on 2-11-08. Parent states the child got a high fever and had a siezure.  The parent took the child to Hospital.
Fussy,moaning,crying unconsolably ,would not drink,some local rxn.RX /w APAP.
CHILD'S DATE OF BIRTH AND AGE WRITTEN AS 12 ON CONSENT SIGNED BY PERSON IDENTIFYING AS MOM. CHILD IS TOO YOUNG TO RECEIVE VACCINE IN JUNE 2021.
Grandmother called clinic 5/12 states baby received immunization 5/8 states on 5/9 baby had first seizure @ 8:30 p.m. followed by second seizure at 10:30 p.m. Took to ER and admitted for observation until 5/11. Grandmother states only test performed were heart monitor. Also states highest temp was 100.9 and  MD @ ER stated seizure could have been from vaccine received 5/8. Asked her to report it to Health Department. States baby okay at home. No other seizures or complications noted.  Discharge Summary:  This 6 month old Female brought to hospital ER with complaint of e episodes of apnea.  D/C Diagnosis:  Witnessed apneic episodes that have resolved with non recurrent during hospitalization;  No consultations of further follow up 5/30/08-records received-DOS 5/9-5/11/08-DC DX:Witnessed apneic episodes that appear to have resolved with none recurrent during hospitalization. Presented to ED with C/O having stopped breathing. Two episodes of apnea witnessed. PE normal. Temperature 100.9.
Extreme vertigo for ten minutes - walls were tilting wildy, had to hold onto a railing.  The following 24 hours, frequent dizziness when moving, some mild nausea.
Sore underarm; Flu-like symptoms; Congestion; Sore throat; sore underarm; Chest pain; Congestion; shortness of breath; Vomiting; Vaccination site pain; Pain in her left side of her back.; Nausea/expereinced more nausea; Headache; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea/expereinced more nausea), HEADACHE (Headache), VACCINATION SITE PAIN (Vaccination site pain), BACK PAIN (Pain in her left side of her back.) and MYALGIA (Sore underarm) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M70A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cardiomyopathy.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced NAUSEA (Nausea/expereinced more nausea) and HEADACHE (Headache). On 25-Feb-2021, the patient experienced VACCINATION SITE PAIN (Vaccination site pain), BACK PAIN (Pain in her left side of her back.), DYSPNOEA (shortness of breath) and VOMITING (Vomiting). On an unknown date, the patient experienced MYALGIA (Sore underarm), INFLUENZA LIKE ILLNESS (Flu-like symptoms), the first episode of NASAL CONGESTION (Congestion), OROPHARYNGEAL PAIN (Sore throat), PAIN IN EXTREMITY (sore underarm), CHEST PAIN (Chest pain) and the second episode of NASAL CONGESTION (Congestion). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of UNK dosage form. On 25-Feb-2021, NAUSEA (Nausea/expereinced more nausea) and HEADACHE (Headache) had resolved. On 26-Feb-2021, VACCINATION SITE PAIN (Vaccination site pain) and BACK PAIN (Pain in her left side of her back.) had resolved. On 02-Mar-2021, VOMITING (Vomiting) had resolved. At the time of the report, MYALGIA (Sore underarm), INFLUENZA LIKE ILLNESS (Flu-like symptoms), OROPHARYNGEAL PAIN (Sore throat), PAIN IN EXTREMITY (sore underarm), CHEST PAIN (Chest pain) and the last episode of NASAL CONGESTION (Congestion) had resolved and DYSPNOEA (shortness of breath) had not resolved. experienced more nausea on 9-mar-2021 when she had to get a tetanus shot.          No concomitant medications provided. Other treatment included ginger ale and crackers for nausea.    Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: new events,outcome of all the events updated
This spontaneous report as received from a nurse practitioner refers to a 4 months old patient of unknown gender. No information on patient's medical history or concurrent conditions was provided. On 23-DEC-2014, the patient was vaccinated with the dose of PEDVAXHIB lot # K008680 (dose, strength, route of administration and expiration date were not reported) which had temperature excursion. No information on patient's concomitant medication was provided. This is one of several reports from the same reporter. Additional information has been requested.
Joint pain; Muscle spasms; This spontaneous case was reported by a patient and describes the occurrence of MUSCLE SPASMS (Muscle spasms) and ARTHRALGIA (Joint pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026B21A and 047S21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1. On 29-May-2021, the patient experienced MUSCLE SPASMS (Muscle spasms). On 08-Jul-2021, the patient experienced ARTHRALGIA (Joint pain). The patient was treated with DIAZEPAM (VALIUM) for Adverse event, at an unspecified dose and frequency. At the time of the report, MUSCLE SPASMS (Muscle spasms) and ARTHRALGIA (Joint pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.
Idiopathic thrombocytopenic purpura; Itching; Rash on her chest; Cherry angioma; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of IMMUNE THROMBOCYTOPENIA (Idiopathic thrombocytopenic purpura) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On 05-Apr-2021, the patient experienced HAEMANGIOMA OF SKIN (Cherry angioma). On 06-Apr-2021, the patient experienced PRURITUS (Itching) and RASH (Rash on her chest). On 07-Apr-2021, the patient experienced IMMUNE THROMBOCYTOPENIA (Idiopathic thrombocytopenic purpura) (seriousness criterion medically significant). At the time of the report, IMMUNE THROMBOCYTOPENIA (Idiopathic thrombocytopenic purpura), HAEMANGIOMA OF SKIN (Cherry angioma), PRURITUS (Itching) and RASH (Rash on her chest) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Her doctor thinks it an allergic reaction and an early stage ITP (idiopathic thrombocytopenic purpura).  No concomitant medication reported by the reporter.  No treatment medication reported by the reporter  Very limited information regarding these events has been provided at this time. Further information has been requested.; Sender's Comments: Very limited information regarding these events has been provided at this time. Further information has been requested.
a lot of redness that came down the lower part of the arm and spread; Information has been received from a medical assistant via the company representative referring to a 67-year-old female patient. Information about concurrent condition, concomitant medication and medical history was unknown.  On an unknown date, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (strength, dose, frequency, route and lot # were not reported) for prevention of pneumonia. After an unspecified amount of time later, the patient developed a lot of redness that came down the lower part of the arm and spread. She had sought medical attention due to the event. At the reported time, the event had already recovered.   The causal relationship between the event and pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was unknown.